Search company, investor...

Somatix Therapy

Founded Year

1991

Stage

Acquired | Acquired

About Somatix Therapy

Developer of gene therapy technology. The company was formed from the March 1991 merger of Hana Biologics, a publicly held cell therapy company (NASDAQ:HANA) and Somatix, a privately-held gene therapy company based in Cambridge, MA. The combined company will specialize in cell implant and gene therapy approaches to the in vivo production and delivery of therapeutic proteins. The initial focus will be on the research and development of products for the treatment of Type I diabetes and hemophilia. The combined technologies of the new company have broad application to the treatment of numerous other acquired and inherited diseases, including Parkinson's disease and cystic fibrosis, as well as to the development of an improved vascular graft. In January 1992, Somatix Therapy acquired GeneSys Therapeutics of La Jolla, California for stock valued at $32.5MM. GeneSys was specializing in gene therapy for treating central nervous systems diseases and cancer.

Headquarters Location

850 Marina Village Parkway

Alameda, California, 94501,

United States

(510)865-9737

Missing: Somatix Therapy's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Somatix Therapy's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Somatix Therapy

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Somatix Therapy is included in 2 Expert Collections, including Regenerative Medicine.

R

Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

D

Diabetes

1,898 items

Somatix Therapy Patents

Somatix Therapy has filed 1 patent.

The 3 most popular patent topics include:

  • Gesture recognition
  • Hand gestures
  • Smartwatches
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/8/2019

9/7/2021

Smartwatches, Hand gestures, Gesture recognition, Video compression, Wearable devices

Grant

Application Date

11/8/2019

Grant Date

9/7/2021

Title

Related Topics

Smartwatches, Hand gestures, Gesture recognition, Video compression, Wearable devices

Status

Grant

Latest Somatix Therapy News

Cell Genesys to Buy Somatix Therapy - Los Angeles Times

Nov 9, 2022

Cell Genesys to Buy Somatix Therapy L.A. Times Archives Times Staff and Wire Reports Cell Genesys Inc. agreed to acquire Somatix Therapy Corp. for stock valued at $82.8 million, or $3.39 a share, a deal that would create one of the largest developers of gene therapies. The companies said they plan to fire about 20% of their combined work force after they close Alameda-based Somatix’s site there and consolidate research and development. Cell Genesys has about 145 employees and Somatix has about 85. Foster City-based Cell Genesys focuses its research on treating AIDS and cancer, whereas Somatix is seeking treatments for cancer and central nervous system diseases. The companies expect the transaction to be completed in April. Somatix shares fell 62.5 cents to close at $3.19, and Cell Genesys shares fell 31.25 cents to close at $8.81, both in Nasdaq trading.

Somatix Therapy Frequently Asked Questions (FAQ)

  • When was Somatix Therapy founded?

    Somatix Therapy was founded in 1991.

  • Where is Somatix Therapy's headquarters?

    Somatix Therapy's headquarters is located at 850 Marina Village Parkway, Alameda.

  • What is Somatix Therapy's latest funding round?

    Somatix Therapy's latest funding round is Acquired.

  • Who are the investors of Somatix Therapy?

    Investors of Somatix Therapy include Cell Genesys and Forward Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.